Minnetonka, MN – The Alter Pharma Group, a group of generic and pharmacy sales companies, is rebranding all its brands and businesses into A.forall. This change, starting 27 September, represents an important milestone in A.forall’s pursuit of a world where patients can access high-quality, safe and innovative medicines at an affordable price. The move strengthens A.forall’s commitment to #MakingAffordableMedicinesAvailableToAll, offering new synergies and ways to leverage the skills and capacities of its 144 employees around the world.
Alter Pharma started pharmacy sales in 2006. In 2010, it became the Alter Pharma Group after the consolidation of several entities and last year, the group reached an important milestone with its first major acquisition. Its generics business currently markets more than 30 in-house developed added value products that are being sold in more than 60 countries around the globe including US, whereas A.forall’s Benelux Pharmacy House provides medicine shortage services through hospital and retail pharmacies. In 2022 alone, by helping pharmacists to source medicines in shortage, the group managed to bring relief to more than 100,000 hospitalized patients and to supply more than 650,000 months of missing treatments to patients that would otherwise be lacking their medication.
Throughout this journey, the Alter Pharma Group and its brands have always been focused on delivering secure access to high-quality, affordable medicines. The current rebranding will unify businesses and commercial brands of the group*, countless stories and talents, while continuing to make sure that no one is left behind in the pursuit of better health and wellbeing.
